Correlation Between AstraZeneca PLC and Chugai Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both AstraZeneca PLC and Chugai Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AstraZeneca PLC and Chugai Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AstraZeneca PLC and Chugai Pharmaceutical Co, you can compare the effects of market volatilities on AstraZeneca PLC and Chugai Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AstraZeneca PLC with a short position of Chugai Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of AstraZeneca PLC and Chugai Pharmaceutical.
Diversification Opportunities for AstraZeneca PLC and Chugai Pharmaceutical
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between AstraZeneca and Chugai is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding AstraZeneca PLC and Chugai Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chugai Pharmaceutical and AstraZeneca PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AstraZeneca PLC are associated (or correlated) with Chugai Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chugai Pharmaceutical has no effect on the direction of AstraZeneca PLC i.e., AstraZeneca PLC and Chugai Pharmaceutical go up and down completely randomly.
Pair Corralation between AstraZeneca PLC and Chugai Pharmaceutical
Assuming the 90 days horizon AstraZeneca PLC is expected to under-perform the Chugai Pharmaceutical. But the pink sheet apears to be less risky and, when comparing its historical volatility, AstraZeneca PLC is 1.43 times less risky than Chugai Pharmaceutical. The pink sheet trades about -0.42 of its potential returns per unit of risk. The Chugai Pharmaceutical Co is currently generating about -0.12 of returns per unit of risk over similar time horizon. If you would invest 2,280 in Chugai Pharmaceutical Co on August 23, 2024 and sell it today you would lose (211.00) from holding Chugai Pharmaceutical Co or give up 9.25% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
AstraZeneca PLC vs. Chugai Pharmaceutical Co
Performance |
| Timeline |
| AstraZeneca PLC |
| Chugai Pharmaceutical |
AstraZeneca PLC and Chugai Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AstraZeneca PLC and Chugai Pharmaceutical
The main advantage of trading using opposite AstraZeneca PLC and Chugai Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AstraZeneca PLC position performs unexpectedly, Chugai Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chugai Pharmaceutical will offset losses from the drop in Chugai Pharmaceutical's long position.| AstraZeneca PLC vs. Ono Pharmaceutical Co | AstraZeneca PLC vs. GSK plc | AstraZeneca PLC vs. Grifols SA ADR | AstraZeneca PLC vs. Pfizer Inc |
| Chugai Pharmaceutical vs. Ono Pharmaceutical Co | Chugai Pharmaceutical vs. GSK plc | Chugai Pharmaceutical vs. Grifols SA ADR | Chugai Pharmaceutical vs. Pfizer Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |